SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Helus Pharma Reports Second Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Appointed Michael Halstead as Chief Executive Officer to lead Helus Pharma through late-stage develo

HELP

Related stories